MedTrace Logo

COVID-19: Respiratory and Sleep Follow-up

NCT04406324 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 395

Last updated 2024-07-26

No results posted yet for this study

Summary

The current project is a prospective, multicentric cohort study aiming at a multidisciplinary assessment (pulmonary, cardiometabolic, sleep and mental health) of the consequences of infection by SARS-CoV-2, 3 months after the diagnosis in order to better characterize these complications. 400 patients with a positive diagnosis of SARS-CoV-2 will be included in the study 3 months after their diagnosis: They will be followed at 6 months, 1 year, 3 years, and 5 years, as function of their after-effects discovered at 3 months and their evolution.

Conditions

Interventions

OTHER

No intervention

No Intervention. The study consists in a prospective clinical longitudinal follow-up

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Renaud Tamisier, MD, PhD, MBA · University Hospital Grenoble Aples

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-06
Primary Completion
2022-03-07
Completion
2026-06-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04406324 on ClinicalTrials.gov